Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for BioCorRx (BICX) over the last 16 years, with Q3 2025 value amounting to $6.1 million.

  • BioCorRx's Non-Current Assets rose 199014.16% to $6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.7 million, marking a year-over-year increase of 184148.81%. This contributed to the annual value of $267945.0 for FY2024, which is 3279.86% up from last year.
  • As of Q3 2025, BioCorRx's Non-Current Assets stood at $6.1 million, which was up 199014.16% from $6.2 million recorded in Q2 2025.
  • BioCorRx's 5-year Non-Current Assets high stood at $6.2 million for Q1 2025, and its period low was $165851.0 during Q1 2024.
  • In the last 5 years, BioCorRx's Non-Current Assets had a median value of $486213.0 in 2022 and averaged $1.3 million.
  • As far as peak fluctuations go, BioCorRx's Non-Current Assets crashed by 5513.12% in 2023, and later soared by 365957.09% in 2025.
  • BioCorRx's Non-Current Assets (Quarter) stood at $591649.0 in 2021, then decreased by 23.99% to $449684.0 in 2022, then tumbled by 55.13% to $201768.0 in 2023, then soared by 32.8% to $267945.0 in 2024, then surged by 2165.87% to $6.1 million in 2025.
  • Its last three reported values are $6.1 million in Q3 2025, $6.2 million for Q2 2025, and $6.2 million during Q1 2025.